Replies to post #5176 on Quanta Inc (fka QNTA)

[~MulaGreen~]

JD:BSV 4 Cancer by Dr.Andrew Dicken,NMD

Day Spring Cancer Clinic

https://dayspringcancerclinic.com/therapies/blue-scorpion-venom/

In the words of Medolife’s Armani Minasyan:

We have worked with 18,000 patients, most of whom were stage IV – their doctors had given up on them. We’ve seen the venom produce great results and with no side effects. We are way past the ‘snake oil’ phase. We are applying for FDA registration as an orphan drug, meaning if the patient has tried everything else and failed, the FDA would approve its use.

Medolife produces Escozine in a U.S. FDA approved facility in California and a WHO-GMP certified facility in Santo Domingo, Dominican Republic.